Equity Investees (Tables)

6 Months Ended

Jun. 30, 2019

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Consolidated Financial Statements Related to Equity Investees

The following table presents information included in our Unaudited Condensed Consolidated Financial Statements related to our equity investees.

	Three Months Ended June 30,						Six Months Ended June 30,
	2019			2018			2019			2018
Genesis’ share of operating earnings	$	18,918		$	12,266		$	35,788		$	26,780
Amortization of excess purchase price	$	(3,872	)	(3,942		)	(7,745		)	(7,884		)
Net equity in earnings	$	15,046		$	8,324		$	28,043		$	18,896
Distributions received	$	20,721		$	18,361		$	38,546		$	37,990

Schedule of Balance Sheet Information for Equity Investees

The following tables present the unaudited balance sheet and income statement information (on a 100% basis) for Poseidon (which is our most significant equity investment):

	June 30, 2019			December 31, 2018
BALANCE SHEET DATA:
Assets
Current assets	$	17,230		$	18,911
Fixed assets, net	194,398			202,116
Other assets	2,310			886
Total assets	$	213,938		$	221,913
Liabilities and equity
Current liabilities	$	16,611		$	15,909
Other liabilities	237,158			242,881
Equity	(39,831		)	(36,877		)
Total liabilities and equity	$	213,938		$	221,913

Schedule of Operations for Equity Investees

	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
INCOME STATEMENT DATA:
Revenues	$	34,387	$	27,250	$	65,439	$	56,194
Operating income	$	25,655	$	19,325	$	47,960	$	39,672
Net income	$	23,295	$	17,432	$	43,145	$	36,010